From September 2008 until August 1, 2018, Dan was Senior Vice President & General Counsel and a member of the Corporate Executive Team of GSK. As General Counsel, he was responsible for leading the company’s legal department in protecting GSK’s intellectual property, managing litigation, supporting business development transactions, as well as risk management.
Before joining GSK, he was a Partner at the Washington law firm Sidley Austin LLP, where he represented pharmaceutical companies and trade associations on matters related to the US Food and Drug Administration (FDA) and government regulations. Dan was formerly Chief Counsel for the FDA.
Dan holds a bachelor’s degree in Industrial and Labor Relations from Cornell University and a juris doctor degree from Columbia University School of Law, where he was a member of the Law Review and a Kent Scholar. After graduation from law school, he was a law clerk for the US Circuit Court of Appeals for the District of Columbia Circuit. He was the 2012 CPR Corporate Leadership Award recipient and, in 2013, was named a 'Legend in the Law' at the Burton Awards.